P

Premier

Healthcare data analytics and supply chain

Principal 2 Data Scientist

Full-TimeUpdated on 10/23/2026Deadline 11/6/26
$141k - $234k+ Employee incentive plan
Expert
Bachelor's, Master's
Remote in USA
RemoteRemote within the United States; travel 1–20% within the US.
Data & AnalyticsData Science

About the job

Requirements
  • Apply knowledge of statistics, machine learning, programming, data modeling, simulation, and advanced mathematics to analyze complex, high-dimensional datasets and develop analytical methods and algorithms.
  • Use healthcare datasets, including electronic health records, administrative billing data, and post-adjudicated claims data.
  • Have 10 or more years of applicable work experience.
  • Have a bachelor's degree.
  • Remain in a stationary position for prolonged periods of time.
  • Adapt to changing priorities and meet deadlines.
  • Pay attention to detail.
  • Operate computer programs and software.
  • Communicate effectively with audiences in person and electronically.
  • Have day-to-day contact with coworkers and/or the public.
  • Make independent decisions.
  • Work collaboratively in close quarters with peers and interruptions.
Responsibilities
  • Produce innovative solutions and thought leadership publications or patents through exploratory data analysis of complex, high-dimensional datasets.
  • Design, develop, and evaluate methodologies and advanced algorithms for clinically and operationally relevant end-user analytics.
  • Work with subject matter experts, academic institutions, members, and product engineers to translate prototypes into products, services, and features.
  • Work with internal and external subject matter experts to identify novel methodologies and artificial intelligence and machine learning approaches to improve healthcare quality and efficiency.
  • Work with developers and architects to translate prototypes into products, services, and features, and provide leadership and guidelines for large-scale implementation.
  • Extract value from data using analytical approaches and advanced algorithms.
  • Serve as a subject matter expert in business domains including cost, clinical, and master data management.
  • Participate in data exploration and conceptual design for strategic initiatives.
  • Generate and test hypotheses, and analyze and interpret product experiment results.
  • Facilitate and lead meetings with business customers and information technology teams to gather and document requirements.
  • Analyze business requirements, procedures, and problems; design solutions and make recommendations.
  • Use clinical or technical background to interpret user needs and translate them into clinically meaningful methodologies and products.
  • Develop features and stories from requirements for product backlogs.
  • Generate peer-reviewed publications highlighting innovative methodologies.
  • Create patent submissions to protect intellectual property.
  • Present innovative work publicly at conferences and symposiums.
  • Provide data, data-relationship, and data-science-practice advice, demonstrations, and presentations to colleagues, clients, and management.
  • Provide mentoring and training.
  • Develop project estimates and work plans independently or through indirect team supervision.
  • Identify, develop, review, and evolve best practices, standards, operating procedures, and processes.
  • Participate in reviews of team-member deliverables.
Desired Qualifications
  • A clinical or public health background and understanding of how clinicians deploy analytics for quality improvement and population health management.
  • Strong business and healthcare analytics, statistics, simulation, advanced mathematics, data search, and matching experience.
  • Experience facilitating requirements gathering and analysis with customers.
  • Technical data skills, including SQL and data modeling.
  • Healthcare research experience using large patient datasets.
  • Software design and development experience, including statistics and artificial intelligence or machine learning.
  • A record of publishing as a first or lead author in high-impact peer-reviewed journals and experience submitting patent applications.
  • Customer engagement, collaboration, and conflict-management experience.
  • Experience teaching in a related domain in a university setting.
  • A master's degree.

About the company

Premier partners with hospitals and health systems to improve care and lower costs by offering integrated data and analytics, supply chain solutions, and advisory services. Its subscription data and analytics platform, combined with the company’s large U.S. group purchasing organization (GPO) and consulting services, gives member facilities insights, negotiated prices on medical supplies and pharmaceuticals, and guidance on performance improvements. Data analytics help providers improve clinical outcomes and financial performance, while the supply chain platform reduces costs and boosts efficiency through negotiated purchasing. Its advantage comes from a large, interconnected network that combines data, purchasing leverage, and expert advisory support in one ecosystem, with the goal of helping providers deliver better patient outcomes while controlling costs.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Charlotte, North Carolina

Founded

1968

Get referred to Premier

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 2026 court victory restored GPO use for eligible 340B outpatient drug inventory.
  • Premier launched a multi-year technology investment program on February 4, 2026.
  • New AI and product hires in September 2026 support faster cross-sell into providers.

What critics are saying

  • FY2026 first-quarter revenue fell 3% and adjusted EBITDA dropped 12%, signaling softness.
  • Patient Square's $2.6 billion buyout suspended dividends and withdrew FY2026 guidance.
  • GPO dependence faces structural pressure if hospitals shift purchasing to internalized sourcing teams.

What makes Premier unique

  • Premier pairs $86 billion purchasing scale with integrated analytics and supply chain tools.
  • September 21, 2026 appointments push an AI-first product strategy under Emad Rizk.
  • HSHS expanded partnership on September 2026 shows Premier still wins transformation mandates.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • Paid Vacation
  • Performance Bonus
  • Professional Development Budget

Growth & Insights and Company News

6 month growth

4%

1 year growth

16%

2 year growth

15%
Associated Press
Oct 21st, 2026
Premier demos AI supply chain and quality tools in live health system use ahead of 2027 launch

Premier, a healthcare improvement company, unveiled live demonstrations of two AI-enabled products at its 2026 Breakthroughs Conference on October 21, 2026. Both were co-developed with health systems and are already in use ahead of planned 2027 availability. Supply Chain Intelligence helps health systems find and prioritise savings. Users can ask an AI agent why spending is rising and move straight to opportunities such as rebates and product conversions. It is in daily use across 25 health systems, and general availability is targeted for 2027. Quality and Performance combines quality measures, benchmarks and improvement workflows in one application. Three health systems use it daily, and 200 more hospitals are giving feedback. It is targeted for release in January 2027. Chief executive officer Dr. Emad Rizk said the aim is to help providers cut 2% to 5% of operating cost.

BioPharma Watch
Oct 7th, 2026
QT Imaging's Breast Acoustic CT(TM) scanner now available through national group purchasing agreement with Premier.

QT Imaging's Breast Acoustic CT(TM) scanner now available through national group purchasing agreement with Premier. Key Takeaway: QT Imaging Holdings, Inc. has announced that its Breast Acoustic CT(TM) scanner is now available through a national group purchasing agreement with Premier, Inc. This partnership, facilitated by NXC Imaging, aims to enhance the distribution of this innovative, radiation-free imaging technology for breast health management. The agreement is expected to improve accessibility for healthcare providers. Market sentiment analysis. Positive factors. * QT Imaging's Breast Acoustic CT(TM) scanner is now more accessible. * The agreement with Premier enhances distribution capabilities. * The technology is radiation-free, promoting safer breast health management. NOVATO, Calif.-(BUSINESS WIRE)-QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its U.S. distribution partner, NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA, Inc., has entered into a national group purchasing agreement with Premier, Inc. covering the QTI Breast Acoustic CT(TM) scanner and provid Frequently asked questions. What is the Breast Acoustic CT(TM) scanner? The Breast Acoustic CT(TM) scanner is an innovative, radiation-free imaging technology designed for breast health management. Who is QT Imaging's distribution partner? QT Imaging's U.S. distribution partner is NXC Imaging, Inc., a subsidiary of Canon Medical Systems USA. What does the agreement with Premier entail? The agreement with Premier allows for national group purchasing of the Breast Acoustic CT(TM) scanner, improving its accessibility. Why is the scanner considered safer? The Breast Acoustic CT(TM) scanner is radiation-free, making it a safer option for breast imaging.

PR Newswire
Sep 28th, 2026
Tulavi Therapeutics wins breakthrough designation from Premier for nerve surgery hydrogel cap

Tulavi Therapeutics has received a national group purchasing agreement and Breakthrough Technology Designation from Premier, Inc. for its allay™ Hydrogel Cap. Effective 15 September 2026, the agreement enables Premier members to access pre-negotiated pricing for the device, which is the first fully resorbable, in situ forming medical device designed to reduce symptomatic neuroma formation. Approximately 600,000 amputations and 1.9 million peripheral nerve surgeries are performed annually in the US. Neuromas, which can cause chronic pain, form when severed peripheral nerves heal erratically. The allay™ Hydrogel Cap is built on technology used in over 10 million patients worldwide. The sutureless device remains in place for approximately eight months, protecting nerves during the critical neuroma formation period.

MarketScreener
Sep 21st, 2026
Premier, Inc. announces executive appointments.

Premier, Inc. announces executive appointments. Published on 09/21/2026 at 04:52 pm EDT S&P Capital IQ Premier, Inc. had appointed Florian Quarré as Chief AI and Analytics Officer. Quarré will lead Premier?s enterprise AI, data, analytics and technology strategy, including its new AI & Analytics Center of Excellence. His mandate is to accelerate Premier?s evolution into an AI-first organization, harnessing the collective power of Premier?s data and embedding intelligence into products, solutions and workflows that help members uncover opportunity, anticipate risk and improve clinical, operational and financial performance. Quarré brings more than 20 years of healthcare, AI and transformation experience. Most recently, he served as Senior Partner and Head of Digital Transformation at HealthScape Advisors following senior leadership roles at PwC, Ciox Health, ExponentialAI and Deloitte. Quarré is a frequent industry speaker and guest lecturer at Georgetown University. Premier, Inc. had appointed Matthew Zubiller, FACHE, as Chief Business and Product Officer. Zubiller will lead Premier?s product operations and enterprise strategy. He is responsible for identifying the most pressing needs facing healthcare providers, determining where Premier is uniquely positioned to solve them, and prioritizing investment in solutions that deliver measurable member and business value. Zubiller brings 30 years of experience leading healthcare, technology and services organizations, with deep expertise in product strategy, innovation, commercialization, revenue cycle and growth. Prior to joining Premier, he served as CEO and Board Member of Your Behavioral Health and CEO of e4health. He also previously held executive leadership roles at McKesson/Change Healthcare, AMN Healthcare and Smile Brands. (C) S&P Capital IQ - Business Wire - 2026

PR Newswire
Sep 10th, 2026
Quanta Dialysis Technologies, Inc. to be honored at Premier, Inc.'s annual Supplier Innovation Celebration.

Quanta Dialysis Technologies, Inc. to be honored at Premier, Inc.'s annual Supplier Innovation Celebration. Sep 10, 2026, 09:00 ET BEVERLY, Mass., Sept. 10, 2026 /PRNewswire/ - Quanta Dialysis Technologies(R) today announced that it will be honored during Premier's annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition, which is scheduled to take place October 6-8 at the Gaylord National Resort & Convention Center in National Harbor, MD. The Innovation Celebration recognizes groundbreaking healthcare technologies launched throughout the year and highlights how these products help improve the health of communities. "We are honored to be recognized by Premier for innovation that is making a meaningful difference for both dialysis patients and their care teams," said Alejandro Galindo, Chief Executive Officer of Quanta Dialysis Technologies. "The Quanta Dialysis System was specifically designed to simplify the delivery of high-quality dialysis across care settings. This recognition reinforces our commitment to advancing kidney care and expanding access to quality dialysis treatment from the hospital to the home." The Quanta(R) Dialysis System is a compact, versatile hemodialysis platform designed to support kidney replacement therapy across the care continuum. It is the first-and-only FDA-approved, dialysis device that offers intermittent hemodialysis (IHD), sustained low-efficiency dialysis (SLED), continuous renal replacement therapy (CRRT) and home hemodialysis (HHD), all in one compact, easy-to-use platform. This innovative system combines precision, flexibility, and simplified maintenance to help care teams streamline dialysis delivery, while promoting greater access to quality treatment. Quanta's on-demand dialysate technology effectively eliminates the need for bags, allowing for smoother, more efficient workflows for care staff and dramatically reduced cost per treatment and supplies storage footprint for health systems. Premier's Innovation Celebration is entering its 15th year of recognizing and honoring healthcare supplier innovation. More than 600 suppliers exhibit at the Breakthroughs Conference each year. Winners are selected by a national committee of clinicians, physicians and supply chain experts who evaluate each technology and its impact on patient care. "Premier recognizes Quanta for its commitment to moving healthcare forward," said Bruce Radcliff, President of Supply Chain Services at Premier. "Recognized at our 2026 Innovation Celebration, the Quanta Dialysis System reflects our shared mission to transform healthcare through improving efficiency, quality and patient outcomes. We are proud to work with Quanta and commend them for their continued innovation." About Premier Inc. Premier is a leading technology-driven healthcare improvement company. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers and payers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, advisory services and other solutions in service of our mission to improve the health of communities. About Quanta Dialysis Technologies Inc. Quanta Dialysis Technologies is committed to making high-quality and cost-effective dialysis accessible to every patient, in every setting, with its Quanta Dialysis System. In 2022, the company's Quanta Dialysis System became the first and only FDA-cleared device designed to perform intermittent hemodialysis (IHD), sustained low efficiency dialysis (SLED), and bagless, continuous renal replacement therapy (CRRT) - in one system. The system's innovative on-demand dialysate technology was also awarded the prestigious Royal Academy of Engineering MacRobert Award. In 2024, Quanta received FDA-clearance for home hemodialysis (HHD), offering a high dialysate flow (500 mL/min) system. This year, Quanta became the exclusive contract supplier of dialysis equipment and supplies for Premier members, contract #PP-NS-2201. To learn more, visit www.quantadt.com and follow us on Linkedin. SOURCE Quanta Dialysis Technologies